Abstract

Objective:

The aim of this study was to identify the frequency of intensive care unitacquired paresis (ICU-AP) and predisposing factors for muscle weakness in our ICU patients.

Materials and Methods:

A prospective observational study was conducted in a 25-bed ICU of a tertiary hospital. Patients who were cooperated with muscle strength examination, stayed in ICU more than three days and had no preexisting neuromuscular disorder were included in the study. The diagnosis of hospitalization, need for mechanical ventilation, comorbidities, length of ICU stay, mobilization level, discharge status, and Sequential Organ Failure Assessment (SOFA) were recorded. Manual muscle strength test was assessed according to Medical Research Council scale. Handgrip and finger pinch strength values were recorded.

Results:

Forty-two patients completed muscle strength examination. ICU-AP was determined in 16 (38.09%) patients. Length of ICU stay, mechanical ventilation rate, SOFA score and frequency of decubitus ulcers were higher in patients with ICU-AP (p<0.05). There was a significant relationship only between mechanical ventilation and ICU-AP

Conclusion:

ICU-AP is a common problem in critically ill patients and influences outcomes of patients. Patients without mechanical ventilation may develop ICU-AP and mechanical ventilation can be determined as one of the risk factors for muscle weakness.

Keywords: Intensive care, mechanical ventilation, polyneuropathies

References

  1. Parsons EC, Kross EK, Ali NA, Vandevusse LK, Caldwell ES, Watkins TR, et al. Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilation. J Crit Care 2013;28:1079-85.
  2. Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T, Tripodaki E, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care 2010;14:R74.
  3. Witteveen E, Wieske L, de Beer FM, Juffermans NP, Verhamme C, Schultz MJ, et al. No association between systemic complement activation and intensive care unit-acquired weakness. Ann Transl Med 2018;6:115.
  4. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-67.
  5. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2014:CD006832.
  6. Apostolakis E, Papakonstantinou NA, Baikoussis NG, Papadopoulos G. Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth 2015;29:112-21.
  7. Hansen-Flaschen J, Cowen J, Polomano RC. Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med 1994;22:732-3.
  8. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800.
  9. Barreiro E. Models of disuse muscle atrophy: therapeutic implications in critically ill patients. Ann Transl Med 2018;6:29.
  10. Nguyen The L, Nguyen Huu C. Critical illness polyneuropathy and myopathy in a rural area in Vietnam. J Neurol Sci 2015;357:276-81.
  11. Shechtman O, Gestewitz L, Kimble C.Reliability and validity of the DynEx dynamometer. J Hand Ther 2005;18:339-47.
  12. Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008;178:261-8.
  13. Thabet Mahmoud A, Tawfik MAM, Abd El Naby SA, Abo El Fotoh WMM, Saleh NY, Abd El Hady NMS. Neurophysiological study of critical illness polyneuropathy and myopathy in mechanically ventilated children; additional aspects in paediatric critical illness comorbidities. Eur J Neurol 2018;25:991-e76.
  14. Sánchez Solana L, Goñi Bilbao I, Ruiz García P, Díaz Agea JL, Leal Costa C. Acquired neuromuscular dysfunction in the intensive care unit. Enferm Intensiva 2018;29:128-37.
  15. Kramer CL. Intensive Care Unit-Acquired Weakness. Neurol Clin 2017;35:723-36.
  16. Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008;178:261-8.
  17. De Jonghe B, Cook D, Sharshar T, Lefaucheur JP, Carlet J, Outin H. Acquired neuromuscular disorders in critically ill patients: a systematic review. Groupe de Reflexion et d’Etude sur les Neuromyopathies En Reanimation. Intensive Care Med 1998;24:1242-50.
  18. Wigodski S, Carrasco F, Bunout D, Barrera G, Hirsch S, de la Maza MP. Sarcopenia: The need to establish different cutoff points of fat-free mass for the Chilean population. Nutrition 2019;57:217-24.
  19. Dietrich C, Cardoso JR, Vargas F, Sanchez EC, Dutra FH, Moreira C, et al. Functional ability in younger and older elderlies after discharge from the intensive care unit. A prospective cohort. Rev Bras Ter Intensiva 2017;29:293-302.
  20. Peñuelas O, Muriel A, Frutos-Vivar F, Fan E, Raymondos K, Rios F, et al. Prediction and Outcome of Intensive Care Unit-Acquired Paresis. J Intensive Care Med 2018;33:16-28.

Copyright and license

Copyright © 2019 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite?

1.
Yurdakul FG, Çalışkan Uçkun A, Bodur H, Mutlu NM, Balkız Soyal Ö, Özkoçak Turan I. Intensive Care Unit-acquired Paresis: Risk Factors in Conscious and Cooperative Patients in Intensive Care Units. Turk J Intensive Care. 2019;17(4):190-196. https://doi.org/10.4274/tybd.galenos.2019.15807